Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial

Conditions:   COVID-19;   COVID-19 Drug Treatment;   Severe Acute Respiratory Syndrome Coronavirus 2 Interventions:   Drug: Lopinavir/Ritonavir 200 MG-50 MG Oral Tablet;   Drug: Telmisartan 40Mg Oral Tablet;   Drug: Atorvastatin 20 Mg Oral Tablet Sponsors:   French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS);   Université de Bordeaux;   Programme PACCI Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials